Published in
Elsevier, Autoimmunity Reviews, 8(19), p. 102596, 2020
DOI: 10.1016/j.autrev.2020.102596
Links
Tools
Risk of scleroderma according to the type of immune checkpoint inhibitors
Journal article published in 2020 by
Benjamin Terrier,
Sébastien Humbert,
Laure-Hélène Preta,
Laure Delage 
,
Jérôme Razanamahery,
Sara Laurent-Roussel,
Raphaële Mestiri,
Lauren Beaudeau,
Paul Legendre,
François Goupil,
Jérôme Hadjadj,
Marie-Claude Stolzenberg,
Jean-Marc Treluyer,
Virginie Westeel,
Marie-Blanche Valnet-Rabier
and other authors.
,
Jérôme Razanamahery,
Sara Laurent-Roussel,
Raphaële Mestiri,
Lauren Beaudeau,
Paul Legendre,
François Goupil,
Jérôme Hadjadj,
Marie-Claude Stolzenberg,
Jean-Marc Treluyer,
Virginie Westeel,
Marie-Blanche Valnet-Rabier
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 